Trial Profile
Phase I trial of CNS 102 for amyotrophic lateral sclerosis.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 06 Oct 2012
Price :
$35
*
At a glance
- Drugs CNS 102 (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Adverse reactions
- 06 Oct 2012 New trial record